The 26th Annual Congress of the European Hematology Association (EHA) will take place from 9-17 June 2021. EHA is a highly active HARMONY Partner, and the HARMONY Alliance will participate in this large event for the fifth time. EHA2021 will virtually connect medical professionals, national hematology societies, patient groups, medical industry, and media from all over the world.
HARMONY at EHA2021
The EHA2021 congress program will include a variety of HARMONY contributions:
HARMONY presentations in the EU Projects in Hematology session: p233-1 HARMONY 09 June 2021 10:00 AM - 10:30 am
Oral session New biological and translational insights in CLL: abstract S143: p408-4 (S143) CLINICAL IMPACT OF RECURRENT GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL, IN HARMONY Dr. Larry Mansouri
Scientific Working Group Session ELN-EHA SWG for CML: Chronic myeloid leukemia: p255-4 The CML genomics/HARMONY PLUS project - Prof. Susan Branford -11 June 2021 9:00 AM - 9:00 am
Poster session Chronic lymphocytic leukemia and related disorders – Clinical: abstract EP631: OTHER MALIGNANCIES IN THE HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE, MULTICENTER COHORT STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL, IN HARMONY - Dr. Thomas Chatzikonstantinou
#bigdataforbloodcancer digital journey - powered by HARMONY and EHA: Read, listen or watch:
CLL and CML presentations will be made available as of Friday, June 11, 2021 (09:00 CEST).
All EHA2021 sessions content will be accessible for on-demand viewing until August 15, 2021 on the virtual congress platform. In order to view the congress content EHA2021 registration is required.
The HARMONY Alliance was established in 2017 and by 2021 unites over 100 organizations. Check the various links below for more information
EHA2021 is the annual congress of the European Hematology Association, Partner of the HARMONY Alliance. EHA2021 offers the latest news in hematology and its subspecialties such as cutting-edge evidence-based approaches to diagnosis and treatment, highly anticipated clinical and translational research data and the newest developments in innovative techniques, diagnostic tools, and risk-assessment strategies. EHA2021 knows no bounds and is intended for medical professionals, national hematology societies, patient groups, medical industry, and media worldwide. Last year, the annual congres of EHA evolved from a physical meeting at its conception to a fully-fledged virtual congress due to the ongoing pandemic.
See what other meetings HARMONY is holding and attending by visiting our meetings page. >
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
